75. クッシング病 Cushing disease Clinical trials / Disease details


臨床試験数 : 205 薬物数 : 176 - (DrugBank : 45) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 127

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05436639
(ClinicalTrials.gov)
June 9, 202223/6/2022SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal TumorSPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal TumorAutonomous Cortisol Secretion (ACS);ACTH-Independent Cushing Syndrome;ACTH-Independent Adrenal Cushing Syndrome, SomaticDrug: SPI-62 dose1;Drug: SPI-62 dose 2;Drug: SPI-62 dose 3;Drug: SPI-62 dose 4;Drug: PlaceboSparrow PharmaceuticalsNULLRecruiting18 YearsN/AAll150Phase 2United States;Bulgaria;France;Romania;United Kingdom;Germany;Italy